Evogene (EVGN) Change in Inventory (2021 - 2026)
Evogene (EVGN) posted Change in Inventory of $35000.0 for Q1 2026, up 112.54% sequentially from -$279000.0 in Q4 2025, and up 107.83% YoY from $16840.7 in Q1 2025.
Evogene (EVGN) Change in Inventory (2021 - 2026) Analysis & Trends
Evogene has reported Change in Inventory for 6 years, with the latest figure at $35000.0 in Q1 2026.
- Quarterly Change in Inventory rose 107.83% year-over-year to $35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$537000.0 (up 67.51% YoY) and the FY2025 annual result came in at -$1.0 million, up 20.2% from the prior year.
- Change in Inventory climbed to $35000.0 in Q1 2026 per EVGN's latest filing, from -$279000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $342000.0 in Q2 2023 and troughed at -$669000.0 in Q3 2024.
- A 5-year average of -$165529.4 and a median of -$139000.0 in 2025 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory soared 4633.33% in 2023, then sank 2460.0% in 2024.
- Over 5 years, Change in Inventory stood at -$401000.0 in 2022, then soared by 109.23% to $37000.0 in 2023, then plunged by 1127.03% to -$380000.0 in 2024, then rose by 26.58% to -$279000.0 in 2025, then surged by 112.54% to $35000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $35000.0, -$279000.0, and -$139000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Evogene | 4.38 Mn | 4.38 Mn | 204,000.00 | 35,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,000.00 |
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | -279,000.00 |
| Dec 31, 2025 | -279,000.00 |
| Sep 30, 2025 | -139,000.00 |
| Sep 30, 2025 | -139,000.00 |
| Jun 30, 2025 | -154,000.00 |
| Jun 30, 2025 | -154,000.00 |
| Mar 31, 2025 | -447,000.00 |
| Mar 31, 2025 | -447,000.00 |
| Dec 31, 2024 | -380,000.00 |
| Dec 31, 2024 | -380,000.00 |
| Sep 30, 2024 | -669,000.00 |
| Sep 30, 2024 | -669,000.00 |
| Jun 30, 2024 | -157,000.00 |
| Jun 30, 2024 | -157,000.00 |
| Mar 31, 2024 | -640,000.00 |
| Mar 31, 2024 | -640,000.00 |
| Dec 31, 2023 | 37,000.00 |
| Dec 31, 2023 | 37,000.00 |